Cybin (TSE:CYBN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cybin Inc., a leading neuropsychiatry company, is set to join the Water Tower Research Fireside Chat Series to discuss promising data from its Phase II study on major depressive disorder and the upcoming Phase III PARADIGM program. The company’s innovative treatments aim to revolutionize mental healthcare, addressing significant unmet needs with long-lasting results.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.